2025-26 Grant Recipients

Joseph Barbi, PhD
Joseph Barbi, PhDRoswell Park Comprehensive Cancer Center
Neuritin-mediated immune suppression: a targetable driver of metastatic prostate cancer in bone marrow.
Guocan Wang, Ph.D.
Guocan Wang, Ph.D.The University of Texas MD Anderson Cancer Center
Targeting the Myeloid Metabolic Checkpoint ACOD1 to overcome Immunotherapy Resistance in Prostate Cancer Bone Metastasis.
Ka-wing Fong
Ka-wing FongUniversity of Kentucky Research Foundation
Targeting TRIM28-mediated metabolic-epigenetic crosslink to treat metastatic castration-resistant prostate cancer.
Jia Xu, Ph.D., Runhua Liu, M.D., Ph.D.
Jia Xu, Ph.D., Runhua Liu, M.D., Ph.D.University of Alabama at Birmingham
Combinatory inhibition of Aurora Kinases and EZH2 leads to a synergistic antitumor effect in advanced prostate cancer.
Yiping He, PhD and Jiaoti Huang, MD, PhD
Yiping He, PhD and Jiaoti Huang, MD, PhDDuke University School of Medicine
ASXL2/MLL3/MLL4 complexes in prostate cancer therapy.
Guolan Lu
Guolan LuStanford University
Mapping Stomal Niches with Spatial Multi-Omics to Predict Prostate Cancer Bone Metastasis.
Daniel E. Frigo, Ph.D., Ana Aparicio, M.D.
Daniel E. Frigo, Ph.D., Ana Aparicio, M.D.University of Texas MD Anderson Cancer Center
Targeting Sphingolipid Metabolism to Treat Aggressive Variant Prostate Cancers.

2024-25 Grant Recipients

Dr. James D. Brooks
Dr. James D. Brooks
Stanford University
Dr. Nina Bhardwaj and Dr. Mesude Bicak
Dr. Nina Bhardwaj and Dr. Mesude Bicak
Icahn School of Medicine at Mount Sinai
Dr. Guocan Wang
Dr. Guocan Wang
The University of Texas MD Anderson Cancer Center
Dr. Haolong Li
Dr. Haolong Li
Fred Hutchinson Cancer Center
Dr. Christopher J. Pirozzi and Dr. Jiaoti Huang
Dr. Christopher J. Pirozzi and Dr. Jiaoti Huang
Duke University Medical Center
Tonya J. Webb
Tonya J. Webb
University of Maryland, Baltimore

2023-24 Grant Recipients

Juan Arriaga, Ph.D.
Juan Arriaga, Ph.D.
Icahn School of Medicine at Mount Sinai
Andrew Goldstein, Ph.D.
Andrew Goldstein, Ph.D.
University of California Los Angeles
Craig Morita, M.D., Ph.D.
Craig Morita, M.D., Ph.D.
University of Iowa
Selvarangan Ponnazhagan, Ph.D.
Selvarangan Ponnazhagan, Ph.D.
University of Alabama at Birmingham
UAB O’Neal Invests Partnership Grant Recipient
Rakesh Shiradkar, Ph.D.
Rakesh Shiradkar, Ph.D.
Emory University
Luca Valle, M.D.
Luca Valle, M.D.
University of California Los Angeles

Be a catalyst for the cure.

With your help, the Mike Slive Foundation will generate national awareness and fund the scientific breakthroughs that will save lives and end prostate cancer.